This functionality is implemented using Javascript. It cannot work without it, etc...

We are loading the information...

Skip to main content

Medical Policies

Medical policies are documents that define the plan coverage for technologies, procedures and treatments. The statements of medical necessity in the policies, about whether a technology, procedure, treatment, supply, equipment, drug or other service improves the health outcome of the population for which said technology or treatment was designed are based on scientific evidence, clinical studies and professional opinions from our providers and recognized medical organizations.

Each document displayed on this website is provided for informational purposes only and is not an authorization, explanation of benefits, or contract. Receiving benefits is subject to satisfaction of all terms and conditions of coverage. Medical technology is constantly changing, and we reserve the right to periodically review and update our policies.

ID Title Last Review Next Review Description Access
02.003.003 Policy Num:     02.003.003 Feb 12, 2024 Feb 20, 2025 Single autologous hematopoietic cell transplantation (hct) may be considered medically necessary as salvage... View
02.003.004 Hematopoietic Cell Transplantation for Central Nervous System Embryonal Tumors and Ependymoma Feb 20, 2024 Feb 20, 2025 Embryonal tumors of the central nervous system autologous hematopoietic cell transplantation autologous... View
02.003.006 Hematopoietic Cell Transplantation for Miscellaneous Solid Tumors in Adults Feb 04, 2024 Feb 20, 2025 Autologous or allogeneic hematopoietic cell transplant is considered investigational for the following... View
02.003.007 Hematopoietic Cell Transplantation for Solid Tumors of Childhood Feb 12, 2024 Feb 20, 2025 Autologous hematopoietic cell transplantation may be considered medically necessary for: initial... View
02.003.008 Transcatheter Arterial Chemoembolization to Treat Primary or Metastatic Liver Malignancies Aug 22, 2024 Aug 20, 2025 Transcatheter arterial chemoembolization (tace) of the liver is a proposed alternative to conventional... View
02.003.014 Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes and Myeloproliferative Neoplasms Feb 20, 2024 Feb 20, 2025 Myeloablative allogeneic hematopoietic cell transplantation (allo-hct) may be considered medically... View
02.003.015 RASTREO DEL TUMOR DURANTE LA RADIOTERAPIA Oct 28, 2016 Policy Archived Esta política describe el uso de tiempo real, el rastreo de los objetivos dentro de la fracción durante la... View
02.003.016 INFUSIÓN DE LEUCOCITOS ALOGENEICOS PARA MALIGNIDADES HEMATOLÓGICAS QUE RECURREN DESPUÉS DE UN TRASPLANTE DE CÉLULAS ALOGENEICAS Nov 16, 2017 Policy Archived Donante de infusión de linfocitos (dli), también conocido como leucocitos de donantes o infusión capa... View
02.003.019 Hyperthermic Intraperitoneal Chemotherapy for Select Intra-Abdominal and Pelvic Malignancies Aug 19, 2024 Aug 20, 2025 Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (hipec) at the time of surgery may be... View
02.003.020 AxIllary Reverse Mapping for Prevention of Breast Cancer-Related Lymphedema  Dec 09, 2024 Dec 20, 2025 Axillary reverse mapping/reverse lymphatic mapping performed during sentinel lymph node biopsy to prevent... View
02.003.021 Tumor-Infiltrating Lymphocytes for Advanced Melanoma Sep 20, 2024 Sep 20, 2025 Tumor-infiltrating lymphocyte (til) therapy with an indication approved by the u.s. food and drug... View
02.004.001 Esophageal pH Monitoring Dec 12, 2024 Dec 20, 2025 Esophageal ph monitoring using a catheter or wireless-based system may be considered medically... View
02.004.002 Wireless Capsule Endoscopy  for Gastrointestinal (GI) Disorders Jan 07, 2025 Jan 20, 2026 The wireless capsule endoscopy (ce) uses a noninvasive device to visualize segments of the gastrointestinal... View
02.004.005 Transesophageal Endoscopic Therapies for Gastroesophageal Reflux Disease Jan 07, 2025 Jan 20, 2026 Transesophageal endoscopic therapies are being developed for the treatment of gastroesophageal reflux disease... View
02.004.006 Transanal Radiofrequency Treatment of Fecal Incontinence Dec 09, 2021 Policy Archived Radiofrequency energy has been investigated as a minimally invasive treatment of fecal incontinence, in a... View
02.004.007 ALISIS POR FIBRA OPTICA DE POLIPOS COLORECTALES May 16, 2016 Policy Archived El análisis de pólipos colorectales por medio de fibra óptica no se considera para pago. el significado... View
02.004.048 Nerve Fiber Density Measurement Jan 20, 2025 Jan 20, 2026 Skin biopsy with epidermal nerve fiber density measurement for the diagnosis of small fiber neuropathy may be... View
02.004.049 Percutaneous Electrical Nerve Field Stimulation for Irritable Bowel Syndrome Sep 10, 2024 Jun 20, 2025 Percutaneous electrical nerve field stimulation for abdominal pain in individuals with irritable bowel... View
02.005.001 Pulmonary Function Test Nov 04, 2022 Policy Archived The following specific tests for evaluating pulmonary diseases are considered for payment: pulmonary... View
02.005.002 ASISTENCIA Y MANEJO DEL VENTILADOR MECANICO (VENTILATION ASSIST AND MAGEMENT) Aug 22, 2017 Policy Archived Se consideran para pago estos servicios en el tratamiento de las siguientes enfermedades: síndrome guillain... View

Want to be up to date on topics like health, trending news, useful tips, lifestyles and more?

Subscribe to our blog and don't miss out on anything!

Subscribe to the blog

We want to personalize the content according to your preferences

Please select one or more categories to continue

Thanks for subscribing!

You will receive information of interest in your email.

787-277-6653 787-474-6326